قدِّم طلبك الآن 
الدكتور راميش الانجو
باحث ما بعد الدكتوراه
البريد الإلكتروني
relango@hbku.edu.qaالهاتف
55 166 846موقع المكتب
Segment-6,1st Floor, Building No: 2
الدكتور راميش الانجو
باحث ما بعد الدكتوراه
المؤهلات العلمية
Doctorate of Philosophy (Biochemistry)
Master of Science (Biochemistry)
الكيان
معهد قطر لبحوث الطب الحيوي
Divison
مركز البحوث التطبيقية للسرطان
السيرة الذاتية
Dr. Ramesh Elango obtained his PhD from Bharathidasan University in India. He then joined the Molecular Biology Research Lab at King Saud University, Saudi Arabia for his postdoctoral work.
His work led to the identification of miRNA-based molecular signature associated with lymph node metastasis in breast cancer. In 2019, Dr. Elango joined Qatar Biomedical Research Institute’s Translational Oncology Research Center as a postdoctoral researcher.
Dr. Elango has published more than 20 peer-reviewed research articles and book chapters.
Doctorate of Philosophy (Biochemistry)
Bharathidasan University, Tamil Nadu, India
2004 - 2009
Master of Science (Biochemistry)
Periyar University, Tamil Nadu, India
2001 - 2003
Bachelor of Science (Biochemistry)
Periyar University, Tamil Nadu, India
1998 - 2001
- Identification of molecular signatures associated with breast cancer resistance to chemotherapy using transcriptome and CRISPR/Cas9.
- Identification of the microRNA and long noncoding RNAs (lncRNAs) molecular signature associated with pathological complete response to chemotherapy resistance in Triple Negative breast cancer (TNBC).
- Functional characterization of the role of identified lncRNAs and miRNA in driving tumorogencity and treatment response.
Postdoctoral Researcher
Translational Oncology Research Center, Qatar Biomedical Research Institute, Doha, Qatar
May 2019 - Present
Assistant Research Professor
Stem Cell Unit, King Saud University-Medical City Saudi Arabia
July 2016 - April 2019
Biotechnology Application Specialist
Asila-Riyadh Company, Saudi Arabia
October 2012 - March 2016
Postdoctoral Researcher
Department of Food Science and Nutrition King Saud University, Saudi Arabia
December 2009 - September 2012
- Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo. Sci Rep. 2019 Sep 23;9 (1):13696. doi: 10.1038/s41598-019-50140-0.
- Semin Cancer Biol. 2019 Nov 14. pii: S1044-579X(19)30223-8. doi: 10.1016/j.semcancer.2019.11.006.
- Neoplastic Transformation of Human Mesenchymal Stromal Cells Mediated via LIN28B. Sci Rep. 2019 May 30;9(1):8101. doi: 10.1038/s41598-019-44536-1.
- Naringin induces death receptor and mitochondria-mediated apoptosis in human cervical cancer (SiHa) cells. Food and Chemical Toxicology, 51: 97-105. doi: 10.1016/j.fct.2012.07.033.
- Regulatory effect of epigallocatechin gallate on expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis. Chemico-Biological Interactions 183: 125-32. doi: 10.1016/j.cbi.2009.09.013.
Doctorate Degree was awarded on December 2009 at Bharathidasan University, India